Mendus to participate in upcoming industry conferences
Press release Stockholm, Sweden, February 27, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...
New York United States San Diego Comunidad Autonoma De Cataluna Erik Manting Research Satwinder Kaur Singh
Source: marketscreener.com